nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.0108	0.0108	CcSEcCtD
Sibutramine—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.0104	0.0104	CcSEcCtD
Sibutramine—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.0103	0.0103	CcSEcCtD
Sibutramine—Apathy—Furosemide—dilated cardiomyopathy	0.00975	0.00975	CcSEcCtD
Sibutramine—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00969	0.00969	CcSEcCtD
Sibutramine—Flat affect—Furosemide—dilated cardiomyopathy	0.00967	0.00967	CcSEcCtD
Sibutramine—Blister—Furosemide—dilated cardiomyopathy	0.00967	0.00967	CcSEcCtD
Sibutramine—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0091	0.0091	CcSEcCtD
Sibutramine—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00879	0.00879	CcSEcCtD
Sibutramine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00874	0.00874	CcSEcCtD
Sibutramine—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.00859	0.00859	CcSEcCtD
Sibutramine—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00832	0.00832	CcSEcCtD
Sibutramine—Gastritis—Spironolactone—dilated cardiomyopathy	0.00823	0.00823	CcSEcCtD
Sibutramine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00804	0.00804	CcSEcCtD
Sibutramine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00796	0.00796	CcSEcCtD
Sibutramine—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00751	0.00751	CcSEcCtD
Sibutramine—Gout—Furosemide—dilated cardiomyopathy	0.00746	0.00746	CcSEcCtD
Sibutramine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0074	0.0074	CcSEcCtD
Sibutramine—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00725	0.00725	CcSEcCtD
Sibutramine—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00725	0.00725	CcSEcCtD
Sibutramine—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.0071	0.0071	CcSEcCtD
Sibutramine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00704	0.00704	CcSEcCtD
Sibutramine—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00694	0.00694	CcSEcCtD
Sibutramine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00683	0.00683	CcSEcCtD
Sibutramine—Otitis media—Lisinopril—dilated cardiomyopathy	0.00671	0.00671	CcSEcCtD
Sibutramine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0064	0.0064	CcSEcCtD
Sibutramine—Bladder pain—Furosemide—dilated cardiomyopathy	0.0063	0.0063	CcSEcCtD
Sibutramine—Mental disability—Furosemide—dilated cardiomyopathy	0.00605	0.00605	CcSEcCtD
Sibutramine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00591	0.00591	CcSEcCtD
Sibutramine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00591	0.00591	CcSEcCtD
Sibutramine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00581	0.00581	CcSEcCtD
Sibutramine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00579	0.00579	CcSEcCtD
Sibutramine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00576	0.00576	CcSEcCtD
Sibutramine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00575	0.00575	CcSEcCtD
Sibutramine—Cough increased—Lisinopril—dilated cardiomyopathy	0.00571	0.00571	CcSEcCtD
Sibutramine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00568	0.00568	CcSEcCtD
Sibutramine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00565	0.00565	CcSEcCtD
Sibutramine—Gout—Lisinopril—dilated cardiomyopathy	0.0056	0.0056	CcSEcCtD
Sibutramine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00556	0.00556	CcSEcCtD
Sibutramine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00549	0.00549	CcSEcCtD
Sibutramine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00538	0.00538	CcSEcCtD
Sibutramine—Thirst—Furosemide—dilated cardiomyopathy	0.00531	0.00531	CcSEcCtD
Sibutramine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00529	0.00529	CcSEcCtD
Sibutramine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00529	0.00529	CcSEcCtD
Sibutramine—Purpura—Furosemide—dilated cardiomyopathy	0.00525	0.00525	CcSEcCtD
Sibutramine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00523	0.00523	CcSEcCtD
Sibutramine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00523	0.00523	CcSEcCtD
Sibutramine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00519	0.00519	CcSEcCtD
Sibutramine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00514	0.00514	CcSEcCtD
Sibutramine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00511	0.00511	CcSEcCtD
Sibutramine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00508	0.00508	CcSEcCtD
Sibutramine—Malaise—Spironolactone—dilated cardiomyopathy	0.00505	0.00505	CcSEcCtD
Sibutramine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00505	0.00505	CcSEcCtD
Sibutramine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00501	0.00501	CcSEcCtD
Sibutramine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00496	0.00496	CcSEcCtD
Sibutramine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00494	0.00494	CcSEcCtD
Sibutramine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00481	0.00481	CcSEcCtD
Sibutramine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00474	0.00474	CcSEcCtD
Sibutramine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00473	0.00473	CcSEcCtD
Sibutramine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00471	0.00471	CcSEcCtD
Sibutramine—Dehydration—Furosemide—dilated cardiomyopathy	0.0047	0.0047	CcSEcCtD
Sibutramine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00462	0.00462	CcSEcCtD
Sibutramine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00461	0.00461	CcSEcCtD
Sibutramine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0046	0.0046	CcSEcCtD
Sibutramine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00458	0.00458	CcSEcCtD
Sibutramine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00457	0.00457	CcSEcCtD
Sibutramine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00447	0.00447	CcSEcCtD
Sibutramine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00446	0.00446	CcSEcCtD
Sibutramine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0044	0.0044	CcSEcCtD
Sibutramine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00438	0.00438	CcSEcCtD
Sibutramine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00436	0.00436	CcSEcCtD
Sibutramine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Sibutramine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00433	0.00433	CcSEcCtD
Sibutramine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00432	0.00432	CcSEcCtD
Sibutramine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00428	0.00428	CcSEcCtD
Sibutramine—Eczema—Lisinopril—dilated cardiomyopathy	0.00422	0.00422	CcSEcCtD
Sibutramine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00417	0.00417	CcSEcCtD
Sibutramine—Injury—Lisinopril—dilated cardiomyopathy	0.00413	0.00413	CcSEcCtD
Sibutramine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00409	0.00409	CcSEcCtD
Sibutramine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00406	0.00406	CcSEcCtD
Sibutramine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00404	0.00404	CcSEcCtD
Sibutramine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.004	0.004	CcSEcCtD
Sibutramine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Sibutramine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Sibutramine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00394	0.00394	CcSEcCtD
Sibutramine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00392	0.00392	CcSEcCtD
Sibutramine—Arthritis—Lisinopril—dilated cardiomyopathy	0.0039	0.0039	CcSEcCtD
Sibutramine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00389	0.00389	CcSEcCtD
Sibutramine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00387	0.00387	CcSEcCtD
Sibutramine—Renal failure—Furosemide—dilated cardiomyopathy	0.00383	0.00383	CcSEcCtD
Sibutramine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00379	0.00379	CcSEcCtD
Sibutramine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00379	0.00379	CcSEcCtD
Sibutramine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00377	0.00377	CcSEcCtD
Sibutramine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00376	0.00376	CcSEcCtD
Sibutramine—Sweating—Furosemide—dilated cardiomyopathy	0.00374	0.00374	CcSEcCtD
Sibutramine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00366	0.00366	CcSEcCtD
Sibutramine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00363	0.00363	CcSEcCtD
Sibutramine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00361	0.00361	CcSEcCtD
Sibutramine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00361	0.00361	CcSEcCtD
Sibutramine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00357	0.00357	CcSEcCtD
Sibutramine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00356	0.00356	CcSEcCtD
Sibutramine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00353	0.00353	CcSEcCtD
Sibutramine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00347	0.00347	CcSEcCtD
Sibutramine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00337	0.00337	CcSEcCtD
Sibutramine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00337	0.00337	CcSEcCtD
Sibutramine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00336	0.00336	CcSEcCtD
Sibutramine—Asthma—Lisinopril—dilated cardiomyopathy	0.00328	0.00328	CcSEcCtD
Sibutramine—Influenza—Lisinopril—dilated cardiomyopathy	0.00328	0.00328	CcSEcCtD
Sibutramine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00327	0.00327	CcSEcCtD
Sibutramine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Sibutramine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00325	0.00325	CcSEcCtD
Sibutramine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00323	0.00323	CcSEcCtD
Sibutramine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00319	0.00319	CcSEcCtD
Sibutramine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00317	0.00317	CcSEcCtD
Sibutramine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00316	0.00316	CcSEcCtD
Sibutramine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00315	0.00315	CcSEcCtD
Sibutramine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00313	0.00313	CcSEcCtD
Sibutramine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00313	0.00313	CcSEcCtD
Sibutramine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00307	0.00307	CcSEcCtD
Sibutramine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00305	0.00305	CcSEcCtD
Sibutramine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00302	0.00302	CcSEcCtD
Sibutramine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00302	0.00302	CcSEcCtD
Sibutramine—Flatulence—Furosemide—dilated cardiomyopathy	0.003	0.003	CcSEcCtD
Sibutramine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00299	0.00299	CcSEcCtD
Sibutramine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Sibutramine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00298	0.00298	CcSEcCtD
Sibutramine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00296	0.00296	CcSEcCtD
Sibutramine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00294	0.00294	CcSEcCtD
Sibutramine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00293	0.00293	CcSEcCtD
Sibutramine—Depression—Lisinopril—dilated cardiomyopathy	0.00292	0.00292	CcSEcCtD
Sibutramine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00291	0.00291	CcSEcCtD
Sibutramine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Sibutramine—Rash—Spironolactone—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Sibutramine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00288	0.00288	CcSEcCtD
Sibutramine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Sibutramine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Sibutramine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Sibutramine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Sibutramine—Headache—Spironolactone—dilated cardiomyopathy	0.00286	0.00286	CcSEcCtD
Sibutramine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00284	0.00284	CcSEcCtD
Sibutramine—Anaemia—Furosemide—dilated cardiomyopathy	0.00282	0.00282	CcSEcCtD
Sibutramine—Sweating—Lisinopril—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Sibutramine—Agitation—Furosemide—dilated cardiomyopathy	0.0028	0.0028	CcSEcCtD
Sibutramine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00279	0.00279	CcSEcCtD
Sibutramine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00276	0.00276	CcSEcCtD
Sibutramine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00274	0.00274	CcSEcCtD
Sibutramine—Vertigo—Furosemide—dilated cardiomyopathy	0.00274	0.00274	CcSEcCtD
Sibutramine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00273	0.00273	CcSEcCtD
Sibutramine—Nausea—Spironolactone—dilated cardiomyopathy	0.00271	0.00271	CcSEcCtD
Sibutramine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00267	0.00267	CcSEcCtD
Sibutramine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00263	0.00263	CcSEcCtD
Sibutramine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00261	0.00261	CcSEcCtD
Sibutramine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00259	0.00259	CcSEcCtD
Sibutramine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00254	0.00254	CcSEcCtD
Sibutramine—Confusional state—Furosemide—dilated cardiomyopathy	0.00251	0.00251	CcSEcCtD
Sibutramine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00249	0.00249	CcSEcCtD
Sibutramine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Sibutramine—Shock—Furosemide—dilated cardiomyopathy	0.00245	0.00245	CcSEcCtD
Sibutramine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00243	0.00243	CcSEcCtD
Sibutramine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00241	0.00241	CcSEcCtD
Sibutramine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0024	0.0024	CcSEcCtD
Sibutramine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00238	0.00238	CcSEcCtD
Sibutramine—Anorexia—Furosemide—dilated cardiomyopathy	0.00237	0.00237	CcSEcCtD
Sibutramine—Chills—Lisinopril—dilated cardiomyopathy	0.00236	0.00236	CcSEcCtD
Sibutramine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00235	0.00235	CcSEcCtD
Sibutramine—Hypotension—Furosemide—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Sibutramine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Sibutramine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00229	0.00229	CcSEcCtD
Sibutramine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00225	0.00225	CcSEcCtD
Sibutramine—Tension—Lisinopril—dilated cardiomyopathy	0.00224	0.00224	CcSEcCtD
Sibutramine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00224	0.00224	CcSEcCtD
Sibutramine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00223	0.00223	CcSEcCtD
Sibutramine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00222	0.00222	CcSEcCtD
Sibutramine—Back pain—Lisinopril—dilated cardiomyopathy	0.00221	0.00221	CcSEcCtD
Sibutramine—Somnolence—Furosemide—dilated cardiomyopathy	0.00221	0.00221	CcSEcCtD
Sibutramine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.0022	0.0022	CcSEcCtD
Sibutramine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00216	0.00216	CcSEcCtD
Sibutramine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00215	0.00215	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00215	0.00215	CcSEcCtD
Sibutramine—Tremor—Lisinopril—dilated cardiomyopathy	0.00214	0.00214	CcSEcCtD
Sibutramine—Pain—Furosemide—dilated cardiomyopathy	0.00213	0.00213	CcSEcCtD
Sibutramine—Constipation—Furosemide—dilated cardiomyopathy	0.00213	0.00213	CcSEcCtD
Sibutramine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00212	0.00212	CcSEcCtD
Sibutramine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00211	0.00211	CcSEcCtD
Sibutramine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00209	0.00209	CcSEcCtD
Sibutramine—Malaise—Lisinopril—dilated cardiomyopathy	0.00206	0.00206	CcSEcCtD
Sibutramine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Sibutramine—Syncope—Lisinopril—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Sibutramine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Sibutramine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00205	0.00205	CcSEcCtD
Sibutramine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00203	0.00203	CcSEcCtD
Sibutramine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00202	0.00202	CcSEcCtD
Sibutramine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00201	0.00201	CcSEcCtD
Sibutramine—Cough—Lisinopril—dilated cardiomyopathy	0.00199	0.00199	CcSEcCtD
Sibutramine—Urticaria—Furosemide—dilated cardiomyopathy	0.00197	0.00197	CcSEcCtD
Sibutramine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00197	0.00197	CcSEcCtD
Sibutramine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00197	0.00197	CcSEcCtD
Sibutramine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00195	0.00195	CcSEcCtD
Sibutramine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00195	0.00195	CcSEcCtD
Sibutramine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00195	0.00195	CcSEcCtD
Sibutramine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00194	0.00194	CcSEcCtD
Sibutramine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00192	0.00192	CcSEcCtD
Sibutramine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.0019	0.0019	CcSEcCtD
Sibutramine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00188	0.00188	CcSEcCtD
Sibutramine—Oedema—Lisinopril—dilated cardiomyopathy	0.00187	0.00187	CcSEcCtD
Sibutramine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00187	0.00187	CcSEcCtD
Sibutramine—Infection—Lisinopril—dilated cardiomyopathy	0.00185	0.00185	CcSEcCtD
Sibutramine—Shock—Lisinopril—dilated cardiomyopathy	0.00184	0.00184	CcSEcCtD
Sibutramine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00183	0.00183	CcSEcCtD
Sibutramine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00183	0.00183	CcSEcCtD
Sibutramine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00182	0.00182	CcSEcCtD
Sibutramine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00181	0.00181	CcSEcCtD
Sibutramine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.0018	0.0018	CcSEcCtD
Sibutramine—Asthenia—Furosemide—dilated cardiomyopathy	0.00178	0.00178	CcSEcCtD
Sibutramine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00178	0.00178	CcSEcCtD
Sibutramine—Pruritus—Furosemide—dilated cardiomyopathy	0.00176	0.00176	CcSEcCtD
Sibutramine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00174	0.00174	CcSEcCtD
Sibutramine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0017	0.0017	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.0017	0.0017	CcSEcCtD
Sibutramine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00169	0.00169	CcSEcCtD
Sibutramine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00167	0.00167	CcSEcCtD
Sibutramine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00166	0.00166	CcSEcCtD
Sibutramine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00166	0.00166	CcSEcCtD
Sibutramine—Dizziness—Furosemide—dilated cardiomyopathy	0.00164	0.00164	CcSEcCtD
Sibutramine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00164	0.00164	CcSEcCtD
Sibutramine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00162	0.00162	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00161	0.00161	CcSEcCtD
Sibutramine—Pain—Lisinopril—dilated cardiomyopathy	0.00159	0.00159	CcSEcCtD
Sibutramine—Constipation—Lisinopril—dilated cardiomyopathy	0.00159	0.00159	CcSEcCtD
Sibutramine—Vomiting—Furosemide—dilated cardiomyopathy	0.00158	0.00158	CcSEcCtD
Sibutramine—Rash—Furosemide—dilated cardiomyopathy	0.00157	0.00157	CcSEcCtD
Sibutramine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00157	0.00157	CcSEcCtD
Sibutramine—Headache—Furosemide—dilated cardiomyopathy	0.00156	0.00156	CcSEcCtD
Sibutramine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00154	0.00154	CcSEcCtD
Sibutramine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00153	0.00153	CcSEcCtD
Sibutramine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00148	0.00148	CcSEcCtD
Sibutramine—Nausea—Furosemide—dilated cardiomyopathy	0.00148	0.00148	CcSEcCtD
Sibutramine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00147	0.00147	CcSEcCtD
Sibutramine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00147	0.00147	CcSEcCtD
Sibutramine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00137	0.00137	CcSEcCtD
Sibutramine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00134	0.00134	CcSEcCtD
Sibutramine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00132	0.00132	CcSEcCtD
Sibutramine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00128	0.00128	CcSEcCtD
Sibutramine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00123	0.00123	CcSEcCtD
Sibutramine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00119	0.00119	CcSEcCtD
Sibutramine—Rash—Lisinopril—dilated cardiomyopathy	0.00118	0.00118	CcSEcCtD
Sibutramine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00117	0.00117	CcSEcCtD
Sibutramine—Headache—Lisinopril—dilated cardiomyopathy	0.00117	0.00117	CcSEcCtD
Sibutramine—Nausea—Lisinopril—dilated cardiomyopathy	0.00111	0.00111	CcSEcCtD
